WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Corp Stock Forecast, Predictions & Price Target

Analyst price target for ADPT

Based on 2 analysts offering 12 month price targets for Adaptive Biotechnologies Corp.
Min Forecast
$6.00+27.39%
Avg Forecast
$8.00+69.85%
Max Forecast
$10.00+112.31%

Should I buy or sell ADPT stock?

Based on 2 analysts offering ratings for Adaptive Biotechnologies Corp.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ADPT stock forecasts and price targets.

ADPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-13
lockedlocked$00.00+00.00%2023-10-24

1 of 1

Forecast return on equity

Is ADPT forecast to generate an efficient return?
Company
N/A
Industry
28.84%
Market
39.07%

Forecast return on assets

Is ADPT forecast to generate an efficient return on assets?
Company
N/A
Industry
10.9%

ADPT revenue forecast

What is ADPT's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$176.3M-1.88%
Avg 2 year Forecast
$230.4M+28.23%
Avg 3 year Forecast
$296.3M+64.9%
ADPT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ADPT revenue growth forecast

How is ADPT forecast to perform vs Biotechnology companies and vs the US market?
Company
14.1%
Industry
63.47%
Market
6.63%
ADPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ADPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ADPT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ADPT$4.71$8.00+69.85%Buy
DYN$11.18$21.00+87.84%Strong Buy
EYPT$19.15$28.80+50.39%Strong Buy
BCYC$15.79$47.86+203.08%Strong Buy
EXAI$5.58$10.00+79.21%Strong Buy

Adaptive Biotechnologies Stock Forecast FAQ

Is Adaptive Biotechnologies Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ADPT) stock is to Buy ADPT stock.

Out of 2 analysts, 1 (50%) are recommending ADPT as a Strong Buy, 0 (0%) are recommending ADPT as a Buy, 1 (50%) are recommending ADPT as a Hold, 0 (0%) are recommending ADPT as a Sell, and 0 (0%) are recommending ADPT as a Strong Sell.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.

What is ADPT's revenue growth forecast for 2023-2025?

(NASDAQ: ADPT) Adaptive Biotechnologies's forecast annual revenue growth rate of 14.1% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 63.47%, and while it is forecast to beat the US market's average forecast revenue growth rate of 6.63%.

Adaptive Biotechnologies's revenue in 2023 is $179,690,000.On average, 5 Wall Street analysts forecast ADPT's revenue for 2023 to be $25,525,462,820, with the lowest ADPT revenue forecast at $24,640,322,220, and the highest ADPT revenue forecast at $26,855,345,311. On average, 5 Wall Street analysts forecast ADPT's revenue for 2024 to be $33,358,682,058, with the lowest ADPT revenue forecast at $29,678,413,955, and the highest ADPT revenue forecast at $36,813,973,306.

In 2025, ADPT is forecast to generate $42,897,469,076 in revenue, with the lowest revenue forecast at $41,014,120,358 and the highest revenue forecast at $46,233,033,259.

What is ADPT's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: ADPT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 10.9%.

What is ADPT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ADPT price target, the average ADPT price target is $8.00, with the highest ADPT stock price forecast at $10.00 and the lowest ADPT stock price forecast at $6.00.

On average, Wall Street analysts predict that Adaptive Biotechnologies's share price could reach $8.00 by Nov 13, 2024. The average Adaptive Biotechnologies stock price prediction forecasts a potential upside of 69.85% from the current ADPT share price of $4.71.

What is ADPT's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: ADPT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.